Ascendis Pharma AS

NAS:ASNDHealthcareNASDAQ:NBISTOXX:EDD24BP

$229.95+2.09%At closeAt close · Tue 20 Oct · ≈ AED 844.49 · Market cap $14.34B · Next earnings Wed 11 Nov

ASND · Balance sheet · TradingHolo

EUR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.6	0.4	0.4	0.4	0.6	0.6	+10.1%
Cash & short-term investments	0.7	0.7	0.7	0.4	0.6	0.6	+10.1%
Receivables	0.0	0.0	0.0	0.0	0.2	0.2	−5.2%
Inventory	0.0	0.1	0.1	0.2	0.3	0.3	+2.0%
Total current assets	0.7	0.8	0.9	0.7	1.1	1.1	+4.5%
Property, plant & equipment	0.1	0.1	0.1	0.1	0.1	0.1	+48.3%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0	−7.9%
Long-term investments	0.1	0.1	0.0	0.0	0.0	0.0	+219.5%
Total assets	1.0	1.1	1.1	0.8	1.2	1.3	+10.4%
Payables	0.0	0.1	0.1	0.1	0.1	0.1	−6.0%
Short-term debt	0.0	0.0	0.4	0.4	0.5	0.5	−1.1%
Total current liabilities	0.1	0.1	0.7	0.7	0.9	1.1	+17.7%
Long-term debt	0.0	0.1	0.1	0.2	0.4	0.4	+5.5%
Total debt	0.1	0.2	0.6	0.7	0.9	0.9	+1.7%
Net debt	(0.5)	(0.2)	0.2	0.4	0.3	0.3	−13.9%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	+428.0%
Total liabilities	0.1	0.2	0.8	1.0	1.3	1.5	+14.0%
Total equity	0.8	0.9	0.3	(0.1)	(0.1)	(0.2)	−54.0%
Retained earnings	(1.0)	(1.2)	(1.9)	(2.3)	(2.6)	(2.7)	−5.5%

EUR billionsUpdated Thu 13 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

Statements are reported in EUR; the shares trade in USD.